For Healthcare Professionals Important Safety Information

GDPR Privacy Policy


EEA Data Privacy Policy

Protecting the security and privacy of your personal data is important to Apollo Endosurgery. Therefore, Apollo Endosurgery Inc. and its subsidiaries (“APOLLO ENDOSURGERY”) operate its websites in compliance with applicable laws on data privacy protection and data security.

In the following, we provide information on the kinds of data we collect on APOLLO ENDOSURGERY’s websites, the purposes for which we use such data, and the parties with which we share such data, where applicable.

BY USING OUR WEB SITES, APPLICATIONS, OR SERVICES YOU AGREE TO THE TERMS OF THIS DATA PRIVACY POLICY. IF YOU SUBMIT INFORMATION TO US YOU CONSENT TO THE COLLECTION, USE AND DISCLOSURE OF THAT INFORMATION IN ACCORDANCE WITH THIS DATA PRIVACY POLICY.

Collected data and purpose of processing

We employ cookies on Apollo Endosurgery websites. You will find additional information on this subject in our Cookie Policy.

In addition, we collect personal data (e.g., names, telephone numbers, or e-mail addresses) in connection with the operation of APOLLO ENDOSURGERY’s websites and business only when you have voluntarily provided such data to us (e.g., through registration, contact inquiries, surveys, etc.) and when we are entitled to process or use such data by virtue of permission granted by you or on the basis of a statutory provision.

As a general rule, we use such data only for the purpose for which you released the data to us, such as to answer your inquiries, grant you access to certain information or offerings, or provide you with information about our products or related services.

Sharing of data

Insofar as you have provided your consent or when we are otherwise legally entitled to do so, we will share your personal data with other APOLLO ENDOSURGERY subsidiaries, where applicable, for the purposes indicated above.

In connection with the operation of its website and the services provided by way of the website, APOLLO ENDOSURGERY works with service providers such as hosting or IT maintenance service providers, for example.

These recipients may possibly be located in countries outside of the European Economic Area, in which applicable laws do not offer the same level of data privacy protection as in your home country. In such cases, APOLLO ENDOSURGERY takes measures to ensure an appropriate level of data privacy protection. Data is shared only in connection with and in compliance with applicable laws and regulations. We do not sell or otherwise market your personal data to third parties.

Links to Other Websites

APOLLO ENDOSURGERY’s websites may contain links to other websites. We are not responsible for the privacy practices or the content of other websites.

Questions and comments

APOLLO ENDOSURGERY will respond to all legitimate requests for information and where applicable, to correct, amend, or delete your personal data.

If you wish to make such a request or if you have questions or comments about this Data Privacy Policy, please contact us at:

GDPR@ApolloEndo.com.

This Data Privacy Policy is updated from time to time. The date of the last update was May 16, 2018.

Important LAP-BAND® System Safety Information

Indications: The LAP-BAND AP® Systems is indicated for use in weight reduction for severely obese patients with a Body Mass Index (BMI) of at least 35 or a BMI of at least 30 with one or more severe comorbid conditions, or those who are 100 pounds or more over their estimated ideal weight according to the 1983 Metropolitan Life Insurance Tables (use the midpoint for medium frame). It is indicated for use only in severely obese patients 14 years and older who have failed more conservative weight-reduction alternatives, such as supervised diet, exercise and behaviour modification programs. Patients who elect to have this surgery must make the commitment to accept significant changes in their eating habits for the rest of their lives. Weight loss associated with the LAP-BAND® System has been shown to improve or lead to remission of type 2 diabetes in patients with BMI greater than or equal to 35.

Contraindications: The LAP-BAND® AP System is not recommended for patients under 14, patients with conditions that may make them poor surgical candidates or increase the risk of poor results (e.g., inflammatory or cardiopulmonary diseases, GI conditions, symptoms or family history of autoimmune disease, cirrhosis), who are unwilling or unable to comply with the required dietary restrictions, who have alcohol or drug addictions, or who currently are or may be pregnant.

Warnings: The LAP-BAND® AP System is a long-term implant. Explant and replacement surgery may be required. Patients who become pregnant or severely ill, or who require more extensive nutrition may require deflation of their bands. Anti-inflammatory agents, such as aspirin, should be used with caution and may contribute to an increased risk of band erosion.

Adverse Events: Placement of the LAP-BAND® AP System is major surgery and, as with any surgery, death can occur. Possible complications include the risks associated with the medications and methods used during surgery, the risks associated with any surgical procedure, and the patient’s ability to tolerate a foreign object implanted in the body. Band slippage, erosion and deflation, reflux, obstruction of the stomach, dilation of the oesophagus, infection, or nausea and vomiting may occur. Reoperation may be required. Rapid weight loss may result in complications that may require additional surgery. Deflation of the band may alleviate excessively rapid weight loss or oesophageal dilation.

Important: For full safety information please contact LapBandEU@ReShapeLifesci.com or talk with your doctor.

RESHAPE, RESHAPE LIFESCIENCES, LAP-BAND, the ReShape Lifesciences and the LAP-BAND Logos are trademarks of ReShape Lifesciences, Inc.
©2019 ReShape Lifesciences, Inc. All rights reserved. Powered by Sequence Health.